An MIT economist argues that botched incentives, rather than scientific hurdles, are frustrating the quest for an HIV vaccine. The point that jumped out at us the most: It has become increasingly apparent that an HIV vaccine may need to be administered in combination with antiretroviral drugs, even if a stand-alone vaccine remains the ultimate […]
